Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹2,163 Cr₹1,911 Cr₹1,656 Cr₹1,245 Cr₹777 Cr

What is the latest Consolidated Net Profit of TORRENT PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of TORRENT PHARMACEUTICALS is ₹2,163 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹2,163 Cr
Mar2025₹1,911 Cr
Mar2024₹1,656 Cr
Mar2023₹1,245 Cr
Mar2022₹777 Cr

How is Consolidated Net Profit of TORRENT PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹2,163 Cr
13.19
Mar2025 ₹1,911 Cr
15.39
Mar2024 ₹1,656 Cr
33.02
Mar2023 ₹1,245 Cr
60.22
Mar2022 ₹777 Cr -

Compare Consolidated Net Profit of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹192,703.0 Cr 6.3% 12.2% 45.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,842.0 Cr 1.1% 4.6% 14.2% Stock Analytics
DIVIS LABORATORIES ₹193,860.0 Cr 0.6% 8.3% 8.2% Stock Analytics
CIPLA ₹112,593.0 Cr -1.7% -2.8% -4% Stock Analytics
MANKIND PHARMA ₹105,607.0 Cr 2.6% 1.1% -3% Stock Analytics
DR REDDYS LABORATORIES ₹97,364.9 Cr -3.7% -10.4% -6% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

6.3%

12.2%

45.5%

SENSEX

-1%

-0.9%

-7.5%


You may also like the below Video Courses